Recovered patient antibody treatments against COVID-19 underway
With the continuation of the COVID-19 pandemic and possible vaccines approximately one year away from launch, the race to find a treatment for the disease continues. A growing number of pharmaceutical companies have begun work on recovered patients’ antibody treatments for COVID-19. As monoclonal antibody (mAb) drugs are some of the top sellers in the market today, this approach holds potential, says GlobalData, a leading data and analytics company.
...